Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

Name: Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
License: Public Domain

Dana-Farber Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

follicular lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 343829
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.